Zobrazeno 1 - 10
of 169
pro vyhledávání: '"Laura K, Ferris"'
Autor:
Mohamed‐Eslam F. Mohamed, Yuli Qian, Ronilda D'Cunha, Teresa Sligh, Laura K. Ferris, Ann Eldred, Gweneth F. Levy, Shuai Hao, Shashikanth Gannu, David G. Rizzo, Wei Liu, Sasha Jazayeri, Howard Sofen, Roberto Carcereri De Prati
Publikováno v:
Clinical and Translational Science, Vol 17, Iss 1, Pp n/a-n/a (2024)
Abstract Cedirogant is an inverse agonist of retinoic acid‐related orphan receptor gamma thymus (RORγt) developed for the treatment of moderate to severe chronic plaque psoriasis. Here, we report the results from two phase I studies in which the p
Externí odkaz:
https://doaj.org/article/e6092a073daa4e0988785d2ccda67ab3
Autor:
Tito Onyekweli, BS, Ashima Agarwal, BS, Erik Jaklitsch, BS, Alaina James, MD, PhD, Sonal Choudhary, MD, Laura K. Ferris, MD, PhD, Joseph C. English, III, MD
Publikováno v:
JAAD International, Vol 11, Iss , Pp 126-128 (2023)
Externí odkaz:
https://doaj.org/article/0b0a8c1b84234c098c8fce7b2be0d4d8
Autor:
William F. Maguire, Paul H. Haley, Catherine M. Dietz, Mike Hoffelder, Clara S. Brandt, Robin Joyce, Georgia Fitzgerald, Christopher Minnier, Cindy Sander, Laura K. Ferris, Gyorgy Paragh, Joshua Arbesman, Hong Wang, Kevin J. Mitchell, Ellen K. Hughes, John M. Kirkwood
Publikováno v:
JID Innovations, Vol 3, Iss 2, Pp 100181- (2023)
The documentation of the change in the number and appearance of pigmented cutaneous lesions over time is critical to the early detection of skin cancers and may provide preliminary signals of efficacy in early-phase therapeutic prevention trials for
Externí odkaz:
https://doaj.org/article/7cbb1b859fca45d18e5b872a007ca00b
Autor:
Craig Leonardi, Kristian Reich, Peter Foley, Hideshi Torii, Sascha Gerdes, Lyn Guenther, Melinda Gooderham, Laura K. Ferris, Christopher E. M. Griffiths, Hany ElMaraghy, Heidi Crane, Himanshu Patel, Russel Burge, Gaia Gallo, David Shrom, Ann Leung, Chen-Yen Lin, Kim Papp
Publikováno v:
Dermatology and Therapy, Vol 10, Iss 3, Pp 431-447 (2020)
Abstract Introduction Ixekizumab, a high-affinity monoclonal antibody that selectively targets interleukin-17A, is approved for treatment of moderate-to-severe plaque psoriasis. Our objective was to evaluate the long-term efficacy and safety of ixeki
Externí odkaz:
https://doaj.org/article/9fcdd75b0c314187bca955c0a6fd2339
Autor:
Peng Wang, Meaghan E. Killeen, Tina L. Sumpter, Laura K. Ferris, Louis D. Falo, Jr., Bruce A. Freeman, Francisco J. Schopfer, Alicia R. Mathers
Publikováno v:
Redox Biology, Vol 43, Iss , Pp 101987- (2021)
Psoriasis is a chronic inflammatory skin disease with no cure. Although the origin of psoriasis and its underlying pathophysiology remain incompletely understood, inflammation is a central mediator of disease progression. In this regard, electrophili
Externí odkaz:
https://doaj.org/article/4b0d7cf207144e3e87124caa4fa7109b
Publikováno v:
Dermatology and Therapy. 13:617-627
Autor:
Patricia Markham Risica, Natalie H. Matthews, Laura Dionne, Jennifer Mello, Laura K. Ferris, Melissa Saul, Alan C. Geller, Francis Solano, John M. Kirkwood, Martin A. Weinstock
Publikováno v:
Preventive Medicine Reports, Vol 10, Iss , Pp 310-316 (2018)
Screening for melanoma may save lives, but may also cause patient distress. One key reason that preventative visual skin examinations for skin cancer are not currently recommended is the inadequate available evidence to assess potential harm to psych
Externí odkaz:
https://doaj.org/article/5134cf2f1682463ba42617131c8665e4
Autor:
Jonathan S. Zager, Brian R. Gastman, Sancy Leachman, Rene C. Gonzalez, Martin D. Fleming, Laura K. Ferris, Jonhan Ho, Alexander R. Miller, Robert W. Cook, Kyle R. Covington, Kristen Meldi-Plasseraud, Brooke Middlebrook, Lewis H. Kaminester, Anthony Greisinger, Sarah I. Estrada, David M. Pariser, Lee D. Cranmer, Jane L. Messina, John T. Vetto, Jeffrey D. Wayne, Keith A. Delman, David H. Lawson, Pedram Gerami
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-11 (2018)
Abstract Background The heterogeneous behavior of patients with melanoma makes prognostication challenging. To address this, a gene expression profile (GEP) test to predict metastatic risk was previously developed. This study evaluates the GEP’s pr
Externí odkaz:
https://doaj.org/article/51ad8d737b2d423ab145b5125b6bb24a
Autor:
Mariah M Johnson, Sancy A Leachman, Lisa G Aspinwall, Lee D Cranmer, Clara Curiel-Lewandrowski, Vernon K Sondak, Clara E Stemwedel, Susan M Swetter, John Vetto, Tawnya Bowles, Robert P Dellavalle, Larisa J Geskin, Douglas Grossman, Kenneth F Grossmann, Jason E Hawkes, Joanne M Jeter, Caroline C Kim, John M Kirkwood, Aaron R Mangold, Frank Meyskens, Michael E Ming, Kelly C Nelson, Michael Piepkorn, Brian P Pollack, June K Robinson, Arthur J Sober, Shannon Trotter, Suraj S Venna, Sanjiv Agarwala, Rhoda Alani, Bruce Averbook, Anna Bar, Mirna Becevic, Neil Box, William E Carson, Pamela B Cassidy, Suephy C Chen, Emily Y Chu, Darrel L Ellis, Laura K Ferris, David E Fisher, Kari Kendra, David H Lawson, Philip D Leming, Kim A Margolin, Svetomir Markovic, Mary C Martini, Debbie Miller, Debjani Sahni, William H Sharfman, Jennifer Stein, Alexander J Stratigos, Ahmad Tarhini, Matthew H Taylor, Oliver J Wisco, Michael K Wong
Publikováno v:
Melanoma Management, Vol 4, Iss 1, Pp 13-37 (2017)
Melanoma is usually apparent on the skin and readily detected by trained medical providers using a routine total body skin examination, yet this malignancy is responsible for the majority of skin cancer-related deaths. Currently, there is no national
Externí odkaz:
https://doaj.org/article/8e14d4bd2ae34bdfbf467c03771d28b3
Autor:
Matthew J. Zirwas, Zoe D. Draelos, Janet DuBois, Leon H. Kircik, Angela Y. Moore, Linda Stein Gold, Javier Alonso-Llamazares, Michael Bukhalo, Suzanne Bruce, Kimmie Eads, Lawrence J. Green, Scott T. Guenthner, Laura K. Ferris, Seth B. Forman, Steven E. Kempers, Edward Lain, Charles W. Lynde, David M. Pariser, Darryl P. Toth, Paul S. Yamauchi, Robert C. Higham, David Krupa, Patrick Burnett, David R. Berk
Publikováno v:
JAMA Dermatology.
ImportanceCurrent topical treatment options for seborrheic dermatitis are limited by efficacy and/or safety.ObjectiveTo assess safety and efficacy of roflumilast foam, 0.3%, in adult patients with seborrheic dermatitis affecting the scalp, face, and/